Integrated serum metabolomics and network pharmacology reveal molecular mechanism of Qixue Huazheng formula on peritoneal fibrosis
BackgroundPeritoneal fibrosis (PF) causes peritoneal dialysis (PD) withdrawal due to ultrafiltration failure. Qixue Huazheng formula (QXHZF), comprising Astragalus membranaceus, Centella asiatica, and Ligusticum sinense, is applied to treat PD-related peritoneum injury related; however, the active c...
Saved in:
Main Authors: | Xiaohui Meng, Li Sheng, Yongqing You, Huibo Dai, Manshu Yu, Funing Wang, Ziren Zhou, Yun Shan, Meixiao Sheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1515038/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of the Watson formula and bioimpedance spectroscopy for measuring body volume and calculating kt/V in patients with peritoneal dialysis
by: Sixiu Liu, et al.
Published: (2024-12-01) -
Herbal HuoXueTongFu Formula with anti-inflammatory and fibrinolytic activity regulation for the prevention of postoperative peritoneal adhesions
by: Lili Yang, et al.
Published: (2025-01-01) -
Unveiling risk factors: a prognostic model of frequent peritonitis in peritoneal dialysis patients
by: Qi-jiang Xu, et al.
Published: (2025-01-01) -
Evaluation of Mannheim Peritonitis Index Score for predicting the outcomes in patients with peritonitis
by: Raiba Deshmukh, et al.
Published: (2024-07-01) -
Effect of glucose concentration on peritoneal inflammatory cytokines in continuous ambulatory peritoneal dialysis patients
by: Reha Erkoc, et al.
Published: (2004-01-01)